Cargando…

Characterization of neuraminidase inhibitor‐resistant influenza A(H1N1)pdm09 viruses isolated in four seasons during pandemic and post‐pandemic periods in Japan

BACKGROUND/OBJECTIVES: Japan has the highest frequency of neuraminidase (NA) inhibitor use against influenza in the world. Therefore, Japan could be at high risk of the emergence and spread of NA inhibitor‐resistant viruses. The aim of this study was to monitor the emergence of NA inhibitor‐resistan...

Descripción completa

Detalles Bibliográficos
Autores principales:	Takashita, Emi, Fujisaki, Seiichiro, Kishida, Noriko, Xu, Hong, Imai, Masaki, Tashiro, Masato, Odagiri, Takato
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2013
Materias:	Part 5
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4634248/ https://www.ncbi.nlm.nih.gov/pubmed/23745712 http://dx.doi.org/10.1111/irv.12132

Ejemplares similares

Factors influencing infection by pandemic influenza A(H1N1)pdm09 over three epidemic waves in Singapore
por: Chen, Mark I. C., et al.
Publicado: (2013)

Counting pandemic deaths: comparing reported numbers of deaths from influenza A(H1N1)pdm09 with estimated excess mortality
por: Gran, Jon Michael, et al.
Publicado: (2013)

Differential use of antivirals for treatment of patients with influenza A(H1N1)pdm09 in Germany
por: Reuss, Annicka, et al.
Publicado: (2013)

A(H1N1)pdm09 hemagglutinin D222G and D222N variants are frequently harbored by patients requiring extracorporeal membrane oxygenation and advanced respiratory assistance for severe A(H1N1)pdm09 infection
por: Ruggiero, Tina, et al.
Publicado: (2013)

In Vitro Characterization of Multidrug-Resistant Influenza A(H1N1)pdm09 Viruses Carrying a Dual Neuraminidase Mutation Isolated from Immunocompromised Patients
por: Takashita, Emi, et al.
Publicado: (2020)

Characterization of influenza A(H1N1)pdm09 viruses isolated from Nepalese and Indian outbreak patients in early 2015
por: Nakamura, Kazuya, et al.
Publicado: (2017)

Worldwide transmission and seasonal variation of pandemic influenza A(H1N1)2009 virus activity during the 2009–2010 pandemic
por: Storms, Aaron D., et al.
Publicado: (2013)

Different prognosis in hospitalized patients with influenza one season after the pandemic H1N1 influenza of 2009–2010 in Spain
por: Delgado‐Rodríguez, Miguel, et al.
Publicado: (2013)

Monitoring and Characterization of Oseltamivir-Resistant Pandemic (H1N1) 2009 Virus, Japan, 2009–2010
por: Ujike, Makoto, et al.
Publicado: (2011)

Regional variation in mortality impact of the 2009 A(H1N1) influenza pandemic in China
por: Yu, Hongjie, et al.
Publicado: (2013)

Community knowledge, behaviours and attitudes about the 2009 H1N1 Influenza pandemic: a systematic review
por: Tooher, Rebecca, et al.
Publicado: (2013)

Estimated impact of aggressive empirical antiviral treatment in containing an outbreak of pandemic influenza H1N1 in an isolated First Nations community
por: Xiao, Yanyu, et al.
Publicado: (2013)

Epidemiology and outcomes of adults with asthma who were hospitalized or died with 2009 pandemic influenza A (H1N1) – California, 2009
por: Mortensen, Eva, et al.
Publicado: (2013)

Household economic impact and attitudes toward school closures in two cities in Argentina during the 2009 influenza A (H1N1) pandemic
por: Basurto‐Dávila, Ricardo, et al.
Publicado: (2012)

Severe acute respiratory infections caused by 2009 pandemic influenza A (H1N1) among American Indians—southwestern United States, May 1–July 21, 2009
por: Suryaprasad, Anil, et al.
Publicado: (2013)

Pandemic positives – a seroepidemiology consortium has formed and significant A(H1N1)pdm09 research continues to flow and demand journal pages
por: Hampson, Alan W.
Publicado: (2013)

Immunogenicity and safety of a 2009 pandemic influenza A (H1N1) monovalent vaccine in Chinese infants aged 6–35 months: a randomized, double‐blind, controlled phase I clinical trial
por: Li, Yan‐Ping, et al.
Publicado: (2012)

Macroeconomic impact of a mild influenza pandemic and associated policies in Thailand, South Africa and Uganda: a computable general equilibrium analysis
por: Smith, Richard D., et al.
Publicado: (2013)

Host Adaptation and the Alteration of Viral Properties of the First Influenza A/H1N1pdm09 Virus Isolated in Japan
por: Ainai, Akira, et al.
Publicado: (2015)

Susceptibility of Influenza Viruses to the Novel Cap-Dependent Endonuclease Inhibitor Baloxavir Marboxil
por: Takashita, Emi, et al.
Publicado: (2018)

Next-Generation Sequencing Analysis of the Within-Host Genetic Diversity of Influenza A(H1N1)pdm09 Viruses in the Upper and Lower Respiratory Tracts of Patients with Severe Influenza
por: Takayama, Ikuyo, et al.
Publicado: (2021)

Molecular Evolutionary Analysis of the Influenza A(H1N1)pdm, May–September, 2009: Temporal and Spatial Spreading Profile of the Viruses in Japan
por: Shiino, Teiichiro, et al.
Publicado: (2010)

Household Transmission of Influenza A(H1N1)pdm09 in the Pandemic and Post-Pandemic Seasons
por: Casado, Itziar, et al.
Publicado: (2014)

Delayed emergence of oseltamivir‐resistant seasonal influenza A (H1N1) and pandemic influenza A(H1N1)pdm09 viruses in Myanmar
por: Dapat, Clyde, et al.
Publicado: (2012)

Increased symptom severity but unchanged neuraminidase inhibitor effectiveness for A(H1N1)pdm09 in the 2010–2011 season: comparison with the previous season and with seasonal A(H3N2) and B
por: Kawai, Naoki, et al.
Publicado: (2012)

Repeated Influenza Vaccination Boosts and Maintains H1N1pdm09 Neuraminidase Antibody Titers
por: Hansen, Lena, et al.
Publicado: (2021)

Emergence of H3N2pM‐like and novel reassortant H3N1 swine viruses possessing segments derived from the A (H1N1)pdm09 influenza virus, Korea
por: Pascua, Philippe Noriel Q., et al.
Publicado: (2013)

Influenza surveillance from November 2008 to 2011; including pandemic influenza A(H1N1)pdm09 in Bhutan
por: Wangchuk, Sonam, et al.
Publicado: (2012)

Antigenic Drift of the Influenza A(H1N1)pdm09 Virus Neuraminidase Results in Reduced Effectiveness of A/California/7/2009 (H1N1pdm09)-Specific Antibodies
por: Gao, Jin, et al.
Publicado: (2019)

Hospitalizations from pandemic Influenza [A(H1N1)pdm09] infections among type 1 and 2 diabetes patients in Spain
por: Jiménez‐García, Rodrigo, et al.
Publicado: (2012)

Antibody responses against influenza A(H1N1)pdm09 virus after sequential vaccination with pandemic and seasonal influenza vaccines in Finnish healthcare professionals
por: Strengell, Mari, et al.
Publicado: (2012)

The dynamics of infection and the persistence of immunity to A(H1N1)pdm09 virus in Israel
por: Weil, Merav, et al.
Publicado: (2012)

Serum anti-neuraminidase antibody responses in human influenza A(H1N1)pdm09 virus infections
por: Karunarathna, Herath M. T. K., et al.
Publicado: (2019)

Neuraminidase inhibitor susceptibility surveillance of influenza viruses circulating worldwide during the 2011 Southern Hemisphere season
por: Okomo‐Adhiambo, Margaret, et al.
Publicado: (2013)

Functional Balance between the Hemagglutinin and Neuraminidase of Influenza A(H1N1)pdm09 HA D222 Variants
por: Casalegno, Jean-Sébastien, et al.
Publicado: (2014)

Structural characterization of a protective epitope spanning A(H1N1)pdm09 influenza virus neuraminidase monomers
por: Wan, Hongquan, et al.
Publicado: (2015)

Diversity of antigenic mutants of influenza A(H1N1)pdm09 virus escaped from human monoclonal antibodies
por: Yasuhara, Atsuhiro, et al.
Publicado: (2017)

Detection of influenza A(H3N2) viruses exhibiting reduced susceptibility to the novel cap-dependent endonuclease inhibitor baloxavir in Japan, December 2018
por: Takashita, Emi, et al.
Publicado: (2019)

The first, second and third wave of pandemic influenza A (H1N1)pdm09 in North Denmark Region 2009–2011: a population‐based study of hospitalizations
por: Ørsted, Iben, et al.
Publicado: (2013)

Estimating age‐specific cumulative incidence for the 2009 influenza pandemic: a meta‐analysis of A(H1N1)pdm09 serological studies from 19 countries
por: Van Kerkhove, Maria D., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_7hugsnv56i85on52bso286hp9m